Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton …
E Wronska, M Polkowski, J Orlowska, A Mroz… - …, 2021 - thieme-connect.com
Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …
Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trials
C Sie, T Bright, M Schoeman, P Game, W Tam… - …, 2013 - thieme-connect.com
Background and study aim: Argon plasma coagulation (APC) has been used to ablate
dysplastic and nondysplastic Barrett's esophagus. We determined the longer-term efficacy of …
dysplastic and nondysplastic Barrett's esophagus. We determined the longer-term efficacy of …
Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett's esophagus: US pilot study
T Shimizu, JB Samarasena, KJ Fortinsky… - Endoscopy …, 2021 - thieme-connect.com
Background and study aims A novel technique for Barrett's esophagus (BE) ablation, termed
hybrid APC, has recently been developed. The aims of this US pilot study were to evaluate …
hybrid APC, has recently been developed. The aims of this US pilot study were to evaluate …
Barrett's esophagus and argon plasma coagulation: Buried trouble?
H Lantz, N Vakil - Official journal of the American College of …, 2003 - journals.lww.com
This prospective trial evaluated endoscopic thermoablation with argon plasma coagulation
(APC) in the treatment of 50 Barrett's esophagus (BE) patients with low grade or no …
(APC) in the treatment of 50 Barrett's esophagus (BE) patients with low grade or no …
[HTML][HTML] Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study
C Pedrazzani, F Catalano, M Festini… - World journal of …, 2005 - ncbi.nlm.nih.gov
AIM: This prospective study evaluated the effectiveness of 90 W argon plasma coagulation
(APC) for the ablation of Barrett's esophagus (BE) that is considered to be the main risk …
(APC) for the ablation of Barrett's esophagus (BE) that is considered to be the main risk …
Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's …
KK Basu, B Pick, R Bale, KP West, JS De Caestecker - Gut, 2002 - gut.bmj.com
Introduction: Barrett's epithelium (BE) has malignant potential. Neither acid suppression nor
antireflux surgery produce consistent or complete regression of the metaplastic epithelium …
antireflux surgery produce consistent or complete regression of the metaplastic epithelium …
Mo2016 The new hybrid argon plasma coagulation (hybrid APC) for endoscopic ablation of Barrett's esophagus (BE): the results of the pilot trial
SV Kashin, R Kuvaev, AS Nadezhin… - Gastrointestinal …, 2016 - Elsevier
Results In a total of 12 patients with short segment of BE (< 3cm) complete macroscopic BE
ablation was achieved after a mean of 2.5 (range 1-4) treatment sessions and the rate of …
ablation was achieved after a mean of 2.5 (range 1-4) treatment sessions and the rate of …
[HTML][HTML] Hybrid argon plasma coagulation in patients with Barrett esophagus
O Pech - Gastroenterology & Hepatology, 2017 - ncbi.nlm.nih.gov
OP In Europe, nondysplastic Barrett esophagus is usually treated with proton pump
inhibitors and surveillance; ablative therapy of nondysplastic Barrett esophagus is not …
inhibitors and surveillance; ablative therapy of nondysplastic Barrett esophagus is not …
Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation
H Manner, A May, S Miehlke, S Dertinger… - Official journal of the …, 2006 - journals.lww.com
BACKGROUND Complete reversal of Barrett's epithelium (BE) achieved by treatment with
argon plasma coagulation (APC) is variable. The aim of this prospective study was to …
argon plasma coagulation (APC) is variable. The aim of this prospective study was to …
Argon plasma coagulation (APC) for treatment of Barrett's oesophagus
M Migaczewski, A Budzyński… - Videosurgery and other …, 2009 - termedia.pl
Aim: To determine in a prospective study the efficacy of endoscopic argon plasma
coagulation (APC) in combination with proton pump inhibitors (PPIs) for ablation of Barrett's …
coagulation (APC) in combination with proton pump inhibitors (PPIs) for ablation of Barrett's …